Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators

Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue thro...

Full description

Bibliographic Details
Main Authors: Ma, Mengmeng, Wang, Jing, Jiang, Hao, Chen, Qiushui, Xiao, Yi, Yang, Huanghao, Lin, Li
Other Authors: Institute for Digital Molecular Analytics and Science (IDMxS)
Format: Journal Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/170549
_version_ 1826117178271727616
author Ma, Mengmeng
Wang, Jing
Jiang, Hao
Chen, Qiushui
Xiao, Yi
Yang, Huanghao
Lin, Li
author2 Institute for Digital Molecular Analytics and Science (IDMxS)
author_facet Institute for Digital Molecular Analytics and Science (IDMxS)
Ma, Mengmeng
Wang, Jing
Jiang, Hao
Chen, Qiushui
Xiao, Yi
Yang, Huanghao
Lin, Li
author_sort Ma, Mengmeng
collection NTU
description Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Here, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillator (ScNPs@RB/Ab) for efficient deep-brain phototherapy. We demonstrate that the as-synthesized ScNPs@RB/Ab is capable of converting X-rays into visible light to activate the photosensitizers of rose bengal (RB) for Aβ oxygenation through the scalp and skull. We show that the ScNPs@RB/Ab persistently emitting visible luminescence can substantially minimize the risk of excessive X-ray exposure dosage. Importantly, peptide KLVFFAED-functionalized ScNPs@RB/Ab shows a blood-brain barrier permeability. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects. Our study paves a new pathway to develop high-efficiency transcranial AD phototherapy. STATEMENT OF SIGNIFICANCE: Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Herein, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillators (ScNPs@RB/Ab) for efficient deep-brain phototherapy. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects.
first_indexed 2024-10-01T04:23:23Z
format Journal Article
id ntu-10356/170549
institution Nanyang Technological University
language English
last_indexed 2024-10-01T04:23:23Z
publishDate 2023
record_format dspace
spelling ntu-10356/1705492023-09-19T02:55:32Z Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators Ma, Mengmeng Wang, Jing Jiang, Hao Chen, Qiushui Xiao, Yi Yang, Huanghao Lin, Li Institute for Digital Molecular Analytics and Science (IDMxS) Engineering::Materials Scintillator X-ray Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Here, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillator (ScNPs@RB/Ab) for efficient deep-brain phototherapy. We demonstrate that the as-synthesized ScNPs@RB/Ab is capable of converting X-rays into visible light to activate the photosensitizers of rose bengal (RB) for Aβ oxygenation through the scalp and skull. We show that the ScNPs@RB/Ab persistently emitting visible luminescence can substantially minimize the risk of excessive X-ray exposure dosage. Importantly, peptide KLVFFAED-functionalized ScNPs@RB/Ab shows a blood-brain barrier permeability. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects. Our study paves a new pathway to develop high-efficiency transcranial AD phototherapy. STATEMENT OF SIGNIFICANCE: Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Herein, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillators (ScNPs@RB/Ab) for efficient deep-brain phototherapy. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects. 2023-09-19T02:55:31Z 2023-09-19T02:55:31Z 2023 Journal Article Ma, M., Wang, J., Jiang, H., Chen, Q., Xiao, Y., Yang, H. & Lin, L. (2023). Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators. Acta Biomaterialia, 155, 635-643. https://dx.doi.org/10.1016/j.actbio.2022.10.049 1742-7061 https://hdl.handle.net/10356/170549 10.1016/j.actbio.2022.10.049 36328129 2-s2.0-85141964692 155 635 643 en Acta Biomaterialia © 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
spellingShingle Engineering::Materials
Scintillator
X-ray
Ma, Mengmeng
Wang, Jing
Jiang, Hao
Chen, Qiushui
Xiao, Yi
Yang, Huanghao
Lin, Li
Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title_full Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title_fullStr Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title_full_unstemmed Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title_short Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators
title_sort transcranial deep tissue phototherapy for alzheimer s disease using low dose x ray activated long afterglow scintillators
topic Engineering::Materials
Scintillator
X-ray
url https://hdl.handle.net/10356/170549
work_keys_str_mv AT mamengmeng transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT wangjing transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT jianghao transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT chenqiushui transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT xiaoyi transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT yanghuanghao transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators
AT linli transcranialdeeptissuephototherapyforalzheimersdiseaseusinglowdosexrayactivatedlongafterglowscintillators